Reply to Commentary to Skudlik et al. (2023): why a scoping review and why only Germany?

Схожие документы

• Reply to Commentary to Skudlik et al. (2023): why a scoping review and why only Germany?
  по: Stefanie Skudlik, и др.
  Опубликовано: (2024-06-01)
• Challenges and care strategies associated with the admission to nursing homes in Germany: a scoping review
  по: Stefanie Skudlik, и др.
  Опубликовано: (2023-01-01)
• Artificially intelligent nursing homes: a scoping review of palliative care interventions
  по: Isabel Ronan, и др.
  Опубликовано: (2025-02-01)
• Why Śrīdhara Svāmī? The Makings of a Successful Sanskrit Commentary
  по: Ravi M. Gupta
  Опубликовано: (2020-08-01)
• Why do antioxidants fail to provide clinical benefit?
  по: Warnholtz, Ascan, и др.
  Опубликовано: (2000)